GLPG
Price
$29.63
Change
+$0.08 (+0.27%)
Updated
May 17, 6:59 PM EST
73 days until earnings call
XNCR
Price
$23.03
Change
+$0.57 (+2.54%)
Updated
May 17, 6:59 PM EST
72 days until earnings call
Ad is loading...

GLPG vs XNCR

Header iconGLPG vs XNCR Comparison
Open Charts GLPG vs XNCRBanner chart's image
Galapagos
Price$29.63
Change+$0.08 (+0.27%)
Volume$72.25K
CapitalizationN/A
Xencor
Price$23.03
Change+$0.57 (+2.54%)
Volume$386.58K
CapitalizationN/A
View a ticker or compare two or three
GLPG vs XNCR Comparison Chart

Loading...

GLPGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GLPG vs. XNCR commentary
May 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a Hold and XNCR is a Hold.

COMPARISON
Comparison
May 20, 2024
Stock price -- (GLPG: $29.63 vs. XNCR: $23.03)
Brand notoriety: GLPG and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 119% vs. XNCR: 103%
Market capitalization -- GLPG: $1.97B vs. XNCR: $1.42B
GLPG [@Biotechnology] is valued at $1.97B. XNCR’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than GLPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • GLPG’s TA Score: 5 bullish, 2 bearish.
  • XNCR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than XNCR.

Price Growth

GLPG (@Biotechnology) experienced а +3.78% price change this week, while XNCR (@Biotechnology) price change was +2.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.60%. For the same industry, the average monthly price growth was +5.55%, and the average quarterly price growth was +63.39%.

Reported Earning Dates

GLPG is expected to report earnings on Aug 01, 2024.

XNCR is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (+1.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for GLPG with price predictions.
OPEN
A.I.dvisor published
a Summary for XNCR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
GLPG($1.97B) has a higher market cap than XNCR($1.42B). XNCR YTD gains are higher at: 8.479 vs. GLPG (-27.109).
GLPGXNCRGLPG / XNCR
Capitalization1.97B1.42B139%
EBITDAN/AN/A-
Gain YTD-27.1098.479-320%
P/E Ratio57.90N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
GLPG vs XNCR: Fundamental Ratings
GLPG
XNCR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4194
PRICE GROWTH RATING
1..100
6447
P/E GROWTH RATING
1..100
586
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLPG's Valuation (76) in the Biotechnology industry is in the same range as XNCR (80). This means that GLPG’s stock grew similarly to XNCR’s over the last 12 months.

GLPG's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XNCR (100). This means that GLPG’s stock grew similarly to XNCR’s over the last 12 months.

GLPG's SMR Rating (41) in the Biotechnology industry is somewhat better than the same rating for XNCR (94). This means that GLPG’s stock grew somewhat faster than XNCR’s over the last 12 months.

XNCR's Price Growth Rating (47) in the Biotechnology industry is in the same range as GLPG (64). This means that XNCR’s stock grew similarly to GLPG’s over the last 12 months.

XNCR's P/E Growth Rating (6) in the Biotechnology industry is somewhat better than the same rating for GLPG (58). This means that XNCR’s stock grew somewhat faster than GLPG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLPGXNCR
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
58%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 8 days ago
78%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
GLPGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLULX12.700.02
+0.16%
MassMutual Mid Cap Value Adm
JHTRX17.960.02
+0.11%
JPMorgan Hedged Equity 3 R6
GGQPX20.150.02
+0.10%
Goldman Sachs Mid Cap Growth P
RNGHX60.19-0.11
-0.18%
American Funds New Economy R5E
CTCSX32.14-0.08
-0.25%
Calamos Timpani Small Cap Growth C

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+0.27%
VCYT - GLPG
43%
Loosely correlated
-2.22%
BCRX - GLPG
42%
Loosely correlated
-2.94%
NTLA - GLPG
41%
Loosely correlated
+0.19%
XNCR - GLPG
38%
Loosely correlated
+2.54%
PRME - GLPG
38%
Loosely correlated
+0.57%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+2.54%
VCYT - XNCR
52%
Loosely correlated
-2.22%
NTLA - XNCR
50%
Loosely correlated
+0.19%
PRME - XNCR
50%
Loosely correlated
+0.57%
BEAM - XNCR
49%
Loosely correlated
+3.49%
RLAY - XNCR
47%
Loosely correlated
+2.00%
More